-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Initiates Coverage On Ascentage Pharma Group with Outperform Rating, Announces Price Target of $45

Benzinga·12/04/2025 18:08:27
Listen to the news
Oppenheimer analyst Matthew Biegler initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Outperform rating and announces Price Target of $45.